Beligas Pharmaceuticals

27 products

• High Concentration

  Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

  Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

  €47.00
• High Concentration

  Etho-Masteron 200mg/ml 10ml Vial by Beligas Pharmaceuticals

  Etho-Masteron by Beligas Pharmaceuticals is a high-concentration injectable Drostanolone Enanthate solution, dosed at 200mg/ml in a 10ml vial, engineered to integrate cleanly into structured, periodized cycle protocols where sustained androgenic support is the primary objective. The extended-release enanthate ester makes it particularly well-suited to modern cutting and recomposition blueprints that demand stable hormone levels over multi-week blocks without frequent injection windows. Batch release is governed by HPLC chromatographic quantification against certified reference standards; sterility is confirmed via LAL endotoxin assay — both conducted under GMP-compliant production conditions at Beligas Pharmaceuticals.

  €54.00
• Optimal Dosage

  Propha-Masteron 100mg/ml 10ml Vial by Beligas Pharmaceuticals

  Propha-Masteron is an oil-based injectable solution delivering Drostanolone Propionate at 100mg/ml, distinguished by its capacity to bypass hepatic first-pass metabolism entirely — a pharmacokinetic advantage that oral androgen compounds cannot replicate. Each 10ml multi-dose vial provides a full cycle's supply of pharmaceutical-grade active, with systemic absorption occurring directly through intramuscular tissue into the bloodstream. Quality assurance is built into every lot: HPLC potency verification, LAL endotoxin screening, and GMP-certified filling suites are standard — not optional — at Beligas Pharmaceuticals.

  €46.00
• High Concentration

  Etho-Primobolan 100mg/ml 10ml Vial by Beligas Pharmaceuticals

  Etho-Primobolan by Beligas Pharmaceuticals is a Methenolone Enanthate injectable at 100mg/ml in a 10ml multi-dose vial, engineered to integrate seamlessly into evidence-informed modern cycling strategies — whether as a base compound, a dry-tissue phase anchor, or a bridging agent between heavier blasts. Its long-acting ester supports once- or twice-weekly injection schedules that align with the structured periodisation models favoured by contemporary competitive and recreational athletes. Quality is verified across the full production chain: each batch undergoes HPLC potency assay and LAL endotoxin testing under Beligas's GMP-certified manufacturing framework.

  €68.00
• High Concentration

  Deca-Durabolin 300mg/ml 10ml Vial by Beligas Pharmaceuticals

  Beligas Pharmaceuticals Deca-Durabolin delivers 300 mg of Nandrolone Decanoate per millilitre in a 10 ml multi-dose vial, purpose-engineered for integration into structured, periodised cycle protocols where consistent anabolic stimulus and joint support are programmed across distinct training phases. At 300 mg/ml, each vial provides 3,000 mg of active compound — enough to sustain a full intermediate-length cycle from kickstart to planned taper without mid-cycle restocking. Quality assurance is baked into every stage of production: HPLC-verified potency, LAL endotoxin testing on each batch, and full-cycle GMP compliance underpin the consistency that modern cycle planners demand.

  €52.00
• Fast Acting

  Pheno-NPP 100mg/ml 10ml Vial by Beligas Pharmaceuticals

  Pheno-NPP is a fast-acting Nandrolone Phenylpropionate injectable, dosed at 100 mg/ml in a 10 ml multi-dose vial, engineered specifically around the short phenylpropionate ester's rapid onset characteristics. Unlike longer nandrolone esters, Pheno-NPP reaches peak plasma concentration within 24–48 hours post-injection (confirmed by pharmacokinetic studies of NPP esters), making early-cycle efficacy measurable rather than assumed. Sterility and label accuracy are enforced through HPLC potency verification and LAL endotoxin testing — both validated at the batch level under GMP-certified production conditions at Beligas Pharmaceuticals.

  €48.00
• High Concentration

  Cypo-Testosterone 200mg/ml 10ml Vial by Beligas Pharmaceuticals

  Cypo-Testosterone by Beligas Pharmaceuticals is a single-ingredient injectable androgen — Testosterone Cypionate at 200 mg per millilitre in a 10 ml multi-dose vial — engineered specifically to slot into structured, periodised cycle frameworks. At this concentration, each 1 ml draw delivers a precise 200 mg dose, giving cycle planners clean arithmetic when calculating weekly volume across bulking, maintenance, or recomposition phases. Quality assurance is enforced at every stage: HPLC-verified potency, LAL endotoxin testing, and GMP-certified filling conditions underpin every vial released under the Beligas label.

  €38.00
• Season Highlight

  Etho-Testosterone 300mg/ml 10ml Vial by Beligas Pharmaceuticals

  Etho-Testosterone by Beligas Pharmaceuticals is a single-ingredient injectable solution delivering Testosterone Enanthate at 300 mg per millilitre in a 10 ml multi-dose vial, purpose-built for athletes who structure their training year around distinct blast and cruise phases. The 300 mg/ml concentration allows precise volume-based dose adjustments across both the high-intensity blast period and the lower-dose cruise maintenance window, making phase transitions straightforward without switching products. Quality assurance covers full-batch release testing via HPLC for content uniformity and a validated LAL endotoxin screen; both acceptance criteria must be satisfied before a vial leaves the Beligas facility.

  €38.00
• High Concentration

  Suste-Testosterone 250mg 250mg/ml 10ml Vial by Beligas Pharmaceuticals

  Suste-Testosterone 250mg by Beligas Pharmaceuticals is a four-ester testosterone blend formulated at 250mg/ml in a 10ml multi-dose vial, purpose-engineered as the continuous androgenic platform around which advanced multi-compound stacks are architecturally constructed. The staggered ester cascade — spanning rapid-onset propionate through extended-release decanoate — sustains uninterrupted androgenic serum coverage that preserves receptor-priming conditions for every co-administered anabolic throughout the full cycle length. Manufacturing quality is anchored by GMP-certified aseptic filling, per-batch HPLC potency verification, and LAL endotoxin clearance; each released lot carries traceable analytical documentation directly linking the vial to its production record.

  €39.00
• Verified Manufacturer

  Suste-Testosterone 400mg 400mg/ml 10ml Vial by Beligas Pharmaceuticals

  Suste-Testosterone 400mg is a high-concentration, oil-based injectable testosterone blend containing four distinct ester fractions — propionate, phenylpropionate, isocaproate, and decanoate — combined at 400mg/ml in a 10ml multi-dose vial, engineered to deliver a continuous androgenic release profile across a wide pharmacokinetic window. Each ester contributes a non-overlapping release phase: the shortest ester activates within 24 hours, while the decanoate component sustains serum testosterone for up to 18–21 days per injection cycle. Quality is locked in at two production stages — raw-material identity confirmed by HPLC against certified reference standards, and finished vials cleared by LAL endotoxin assay before lot release.

  €48.00
• Optimal Dosage

  Propha-Testosterone 100mg/ml 10ml Vial by Beligas Pharmaceuticals

  Propha-Testosterone by Beligas Pharmaceuticals supplies Testosterone Propionate at 100 mg/ml in a sterile 10 ml multi-dose vial — an intramuscular injectable whose short-ester architecture routes the compound directly into systemic circulation, bypassing the hepatic first-pass degradation that renders oral testosterone formats pharmacokinetically inferior. Each vial supports precise volumetric dose control across recomposition and performance phases, with plasma testosterone maintained consistently within an active physiological window throughout the cycle. Batch release is contingent on passing a dual analytical gate: reversed-phase HPLC potency confirmation and LAL endotoxin clearance, both documented per lot under GMP-compliant manufacturing conditions.

  €35.00
• Optimal Dosage

  Acro-Trenbolone 100mg/ml 10ml Vial by Beligas Pharmaceuticals

  Acro-Trenbolone is a sterile, oil-based intramuscular solution delivering Trenbolone Acetate at 100 mg per millilitre across a 10 ml multi-dose vial — engineered specifically to bypass hepatic first-pass catabolism and achieve near-complete systemic bioavailability that no oral anabolic compound can match. Because the active hormone enters circulation directly through intramuscular absorption rather than the gastrointestinal tract, essentially none of the injected dose is destroyed before it reaches target androgen receptors. Quality assurance at Beligas Pharmaceuticals is enforced through a layered release protocol: HPLC-verified potency, LAL endotoxin testing, and GMP-certified production conditions — each checkpoint documented before the vial leaves the facility.

  €48.00
• High Concentration

  Etho-Trenbolone 200mg/ml 10ml Vial by Beligas Pharmaceuticals

  Etho-Trenbolone by Beligas Pharmaceuticals is a high-concentration Trenbolone Enanthate injectable, delivering 200 mg per millilitre across a 10 ml multi-dose vial, engineered to slot cleanly into structured modern cycling frameworks where predictable release and manageable injection volume are both priorities. Its extended-release enanthate ester makes it the long-acting trenbolone of choice when planners need to synchronise dosing windows with weekly cycle schedules rather than every-other-day logistics. Quality assurance at Beligas covers every production stage: HPLC potency verification confirms the 200 mg/ml specification, LAL endotoxin screening protects injectable sterility, and GMP-certified filling suites govern the final product release.

  €54.00
• Lab Tested

  Apto-Turinabol 10mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Apto-Turinabol is an oral anabolic agent delivering Chlorodehydromethyltestosterone at 10 mg per tablet — a DHT-lineage compound whose structural 4-chloro substitution selectively modulates androgen receptor binding while eliminating aromatase conversion. Each tablet occupies the lowest effective concentration tier in Beligas Pharmaceuticals' oral steroid range, making receptor-level dose titration straightforward for both introductory and precision protocols. Batch release is governed by HPLC-confirmed content verification and LAL endotoxin screening of all raw material inputs; GMP manufacturing discipline underpins every production step.

  €37.00
• HPLC Verified

  Pro-Dynabol 20mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Pro-Dynabol is an oral anabolic tablet delivering Methandienone at 20 mg per unit, distinguished by a rapid-absorption, short-duration pharmacokinetic profile that demands a structured intraday dosing schedule to maintain stable plasma concentrations. Each pack contains 50 tablets, providing a complete supply for a standard introductory or intermediate oral cycle. Batch-level potency is confirmed through HPLC analysis; every lot produced by Beligas Pharmaceuticals passes documented laboratory verification before release.

  €35.00
• HPLC Verified

  Anavar-Lite 10mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Anavar-Lite by Beligas Pharmaceuticals delivers Oxandrolone at a precisely controlled 10 mg per tablet across a 50-tablet supply, defined by its predictable oral pharmacokinetic profile — an elimination half-life of approximately 9–10 hours that supports twice-daily dosing without plasma level fluctuations. The 10 mg unit dose is particularly suited to users who require granular titration, whether ramping into a cycle or tapering at its conclusion. HPLC quantification of every production batch — cross-referenced against certified reference standards — confirms that each tablet's declared concentration is analytically exact, providing a reliable foundation for plasma-level management throughout the full cycle window.

  €48.00
• Pharma Grade

  Pro-Anavar 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Pro-Anavar is an oral Oxandrolone preparation dosed at 50 mg per tablet — the highest concentration available in this product group — formulated to deliver clinically relevant anabolic activity through the gastrointestinal route, where first-pass hepatic metabolism defines how much active compound ultimately reaches systemic circulation. Because Oxandrolone is administered orally rather than by injection, its absolute bioavailability (approximately 97% of the absorbed fraction, per published pharmacokinetic data) is notably high for an oral steroid, a distinction rooted in the 17α-methyl structural modification that curtails hepatic inactivation. Batch-release quality is enforced by HPLC quantification against certified reference standards; LAL endotoxin screening covers all excipient inputs — every 50-tablet jar reflects Beligas Pharmaceuticals' documented Pharma Grade manufacturing framework.

  €90.00
• Pharma Grade

  Pro-Anadrol 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Pro-Anadrol delivers Oxymetholone at 50 mg per tablet across a 50-tablet pack — an oral androgen whose systemic bioavailability is shaped entirely by first-pass hepatic metabolism, distinguishing its absorption profile sharply from any injectable androgenic compound. Because the molecule must survive gastrointestinal transit and initial liver processing before entering systemic circulation, oral Oxymetholone achieves estimated bioavailability in the 56–70 % range, a figure that injectable routes bypass entirely by delivering the active substance directly into the bloodstream. Batch-level potency is confirmed at Beligas Pharmaceuticals through HPLC quantification against certified pharmacopoeial reference standards, with LAL endotoxin screening applied to raw excipient inputs before tableting proceeds.

  €60.00
• HPLC Verified

  Pro-Winstrol 20mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Pro-Winstrol by Beligas Pharmaceuticals delivers stanozolol at 20 mg per tablet in a 50-tablet oral format, defined primarily by its predictable pharmacokinetic profile: an oral half-life of approximately 9 hours that supports structured twice-daily dosing for stable plasma concentrations. Compared to injectable stanozolol suspension — which carries a half-life closer to 24 hours — the oral form enables more responsive dose adjustments across a cycle. Chromatographic content verification is applied to every production batch; each tablet's active stanozolol quantity is confirmed against certified reference standards prior to lot release.

  €45.00
• HPLC Verified

  Arimidex 1mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Beligas Pharmaceuticals Arimidex delivers anastrozole at 1 mg per tablet across a 50-tablet pack, purpose-built for phase-structured post-cycle frameworks that demand analytically confirmed aromatase inhibition rather than estimated suppression. Separating the AI-driven estrogen-normalisation phase from subsequent SERM-led axis reactivation is now a defining feature of evidence-informed PCT design, and a confirmed 1 mg tablet unit is the dosing foundation that makes granular titration within each phase practical. Every production batch is subject to HPLC quantification verified against certified pharmacopoeial reference standards, with batch integrity further protected by LAL endotoxin testing under cGMP manufacturing conditions.

  €40.00
• HPLC Verified

  Clomid 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Beligas Pharmaceuticals Clomid provides 50 mg of Clomiphene Citrate per tablet — an HPLC-verified SERM formulated to support controlled gonadotropin restoration and systematic testicular recovery within a structured post-cycle framework. The 50-tablet pack accommodates all phases of a declining-step recovery course, from the opening induction dose through the final taper, without requiring additional pack sizes. Every production lot is released only after chromatographic potency confirmation against pharmacopoeial reference standards, ensuring the declared 50 mg content is analytically validated rather than label-estimated.

  €36.00
• Lab Tested

  Supo-Aromasin 25mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Supo-Aromasin is a post-cycle therapy aromatase inhibitor delivering 25 mg of Exemestane per tablet across a 50-tablet supply, formulated specifically to support hormonal axis restoration after androgenic steroid use. By irreversibly binding to aromatase, each tablet eliminates excess estrogen production at the enzymatic level rather than merely blocking receptor access — a mechanistic distinction critical during the PCT window. Every production lot is subjected to HPLC quantification and LAL endotoxin screening within a fully GMP-certified manufacturing environment at Beligas Pharmaceuticals.

  €38.00
• Lab Tested

  Mono-Femara 2.5mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Mono-Femara is a pharmaceutical-grade oral Letrozole preparation — 2.5 mg per tablet, 50 tablets per pack — engineered specifically to support post-cycle estrogen management during hormonal recovery protocols. By inhibiting aromatase activity with high selectivity, it prevents surplus estrogen from suppressing the endogenous testosterone axis during the vulnerable PCT window. Quality is anchored in lot-specific HPLC quantification and LAL endotoxin screening; every tablet released by Beligas Pharmaceuticals carries a confirmed, chromatographically verified active-content value.

  €40.00
• HPLC Verified

  Creto-Proviron 10mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Creto-Proviron by Beligas Pharmaceuticals delivers mesterolone at a precise 10 mg per tablet — a concentration engineered for stepwise dose control within structured modern PCT protocols that prioritise androgen environment optimisation alongside SERM-driven gonadotropin signalling. Where contemporary PCT frameworks move beyond single-agent recovery and layer androgenic support to address libido, mood and estrogenic rebound simultaneously, mesterolone's SHBG-binding and anti-aromatase properties make it a mechanistically rational addition. HPLC-Verified batch release: every 50-tablet unit clears distribution only after chromatographic confirmation of mesterolone content against pharmacopoeial reference standards.

  €40.00
• Lab Tested

  Nolvadex 10mg/tab 50 Tabletten by Beligas Pharmaceuticals

  Beligas Pharmaceuticals Nolvadex supplies Tamoxifen Citrate at 10 mg per tablet in a 50-tablet blister pack, formulated as a selective estrogen receptor modulator for structured hormonal recovery following anabolic androgenic steroid use. Each tablet's low-denomination format allows practitioners to phase doses from induction through final taper using whole-tablet increments, eliminating the estimation error introduced by splitting higher-strength units. Batch-level HPLC chromatographic quantification and LAL endotoxin screening are applied to every production lot before distribution, ensuring the declared 10 mg content is analytically confirmed rather than label-estimated.

  €40.00
• HPLC Verified

  Pro-Clenbuterol 40mcg/tab 50 Tabletten by Beligas Pharmaceuticals

  Pro-Clenbuterol by Beligas Pharmaceuticals is a 40 mcg Clenbuterol hydrochloride oral tablet formulated specifically for measurable thermogenic output — quantified as an elevation in resting body temperature and a documented increase in basal metabolic energy expenditure. Each of the 50 tablets in the pack delivers a precise dose calibrated to support the body's heat-production pathway, making energy expenditure the defining pharmacological lens through which this compound operates. Quality assurance is built into every production lot: HPLC chromatographic verification confirms the 40 mcg declared concentration against pharmacopoeial reference standards before a single blister strip leaves the facility.

  €36.00
• HPLC Verified

  Cytomel-T3 50mcg/tab 50 Tabletten by Beligas Pharmaceuticals

  Beligas Cytomel-T3 delivers Liothyronine Sodium at 50 mcg per tablet across 50 tablets per pack — a pharmaceutically precise oral thyroid hormone formulation engineered for metabolic acceleration in structured cutting protocols. Without concurrent anabolic support, exogenous T3 at performance doses accelerates whole-body protein catabolism, actively degrading lean muscle tissue alongside adipose; pairing with an AAS base is not optional — it is the pharmacological safeguard that keeps nitrogen balance on the positive side of the equation. Batch-level potency is confirmed via HPLC quantification at Beligas Pharmaceuticals' facility, with each release certificate reflecting a chromatographically measured Liothyronine content rather than a nominal label assumption.

  €36.00